Global Generic Drugs Market Professional Survey Report 2018

June 2018 | 115 pages | ID: G04539A73D5EN
QYResearch

Abstracts

This report studies the global Generic Drugs market status and forecast, categorizes the global Generic Drugs market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa).
A generic drug is a pharmaceutical drug that is equivalent to a brand-name product in dosage, strength, route of administration, quality, performance, and intended use. The term may also refer to any drug marketed under its chemical name without advertising, or to the chemical makeup of a drug rather than the brand name under which the drug is sold.

The global average gross margin of generic drugs is in the decreasing trend, from 45.19% in 2011 to 43.56% in 2015. With the situation of global economy, gross margin will be in decreasing trend in the following five years.
The classification of generic drugs includes simple generic drugs, super generic drugs and biosimilars. And the proportion of simple generic drugs in 2015 is about 80% and the proportion is in decreasing trend from 2011 to 2015. The super generic drugs in 2015 are about 18.7% and the proportion is in increasing trend from 2011 to 2015.
North America region is the largest supplier of generic drugs, with a revenue market share nearly 31.5% in 2015. Europe is the second largest supplier of generic drugs, enjoying revenue market share nearly 26.5% in 2015, India is also an important areas, and with the revenue market share is 22.8% in 2015.

The global Generic Drugs market is valued at 210800 million US$ in 2017 and will reach 451800 million US$ by the end of 2025, growing at a CAGR of 10.0% during 2018-2025.

The major manufacturers covered in this report

• Teva
• Novartis - Sandoz
• Mylan
• Sun Pharmaceutical
• Aspen
• Fresenius Kabi
• Pfizer (Hospira)
• Sanofi
• Aurobindo
• Lupin
• Dr. Reddy's
• Apotex
• Cipla
• ENDO (Par Pharmaceutical)
• Stada Arzneimittel
• Krka Group
• Nichi-Iko Pharmaceutical
• Valeant
• Zydus Cadila
• Hikma

Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering

• North America
• Europe
• China
• Japan
• India
• Southeast Asia
• Other regions (Central & South America, Middle East & Africa)

We can also provide the customized separate regional or country-level reports, for the following regions:

• North America
• United States
• Canada
• Mexico
• Asia-Pacific
• China
• India
• Japan
• South Korea
• Australia
• Indonesia
• Singapore
• Rest of Asia-Pacific
• Europe
• Germany
• France
• UK
• Italy
• Spain
• Russia
• Rest of Europe
• Central & South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Saudi Arabia
• Turkey
• Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Simple Generic Drugs
• Super Generic Drugs
• Biosimilars

By Application, the market can be split into

• CNS
• Cardiovascular
• Genitourinary/Hormonal Drugs
• Respiratory
• Rheumatology
• Diabetes
• Oncology
• Others

The study objectives of this report are:

• To analyze and study the global Generic Drugs capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
• Focuses on the key Generic Drugs manufacturers, to study the capacity, production, value, market share and development plans in future.
• Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
• To define, describe and forecast the market by type, application and region.
• To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
• To identify significant trends and factors driving or inhibiting the market growth.
• To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
• To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Generic Drugs are as follows:

• History Year: 2013-2017
• Base Year: 2017
• Estimated Year: 2018
• Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Generic Drugs Manufacturers
Generic Drugs Distributors/Traders/Wholesalers
Generic Drugs Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations

• With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
• Regional and country-level analysis of the Generic Drugs market, by end-use.
• Detailed analysis and profiles of additional market players.

Contents

Global Generic Drugs Market Professional Survey Report 2018

1 INDUSTRY OVERVIEW OF GENERIC DRUGS

1.1 Definition and Specifications of Generic Drugs
  1.1.1 Definition of Generic Drugs
  1.1.2 Specifications of Generic Drugs
1.2 Classification of Generic Drugs
  1.2.1 Simple Generic Drugs
  1.2.2 Super Generic Drugs
  1.2.3 Biosimilars
1.3 Applications of Generic Drugs
  1.3.1 CNS
  1.3.2 Cardiovascular
  1.3.3 Genitourinary/Hormonal Drugs
  1.3.4 Respiratory
  1.3.5 Rheumatology
  1.3.6 Diabetes
  1.3.7 Oncology
  1.3.8 Others
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 Europe
  1.4.3 China
  1.4.4 Japan
  1.4.5 Southeast Asia
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF GENERIC DRUGS

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Generic Drugs
2.3 Manufacturing Process Analysis of Generic Drugs
2.4 Industry Chain Structure of Generic Drugs

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF GENERIC DRUGS

3.1 Capacity and Commercial Production Date of Global Generic Drugs Major Manufacturers in 2017
3.2 Manufacturing Plants Distribution of Global Generic Drugs Major Manufacturers in 2017
3.3 R&D Status and Technology Source of Global Generic Drugs Major Manufacturers in 2017
3.4 Raw Materials Sources Analysis of Global Generic Drugs Major Manufacturers in 2017

4 GLOBAL GENERIC DRUGS OVERALL MARKET OVERVIEW

4.1 2013-2018E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2013-2018E Global Generic Drugs Capacity and Growth Rate Analysis
  4.2.2 2017 Generic Drugs Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2013-2018E Global Generic Drugs Sales and Growth Rate Analysis
  4.3.2 2017 Generic Drugs Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2013-2018E Global Generic Drugs Sales Price
  4.4.2 2017 Generic Drugs Sales Price Analysis (Company Segment)

5 GENERIC DRUGS REGIONAL MARKET ANALYSIS

5.1 North America Generic Drugs Market Analysis
  5.1.1 North America Generic Drugs Market Overview
  5.1.2 North America 2013-2018E Generic Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2013-2018E Generic Drugs Sales Price Analysis
  5.1.4 North America 2017 Generic Drugs Market Share Analysis
5.2 Europe Generic Drugs Market Analysis
  5.2.1 Europe Generic Drugs Market Overview
  5.2.2 Europe 2013-2018E Generic Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 Europe 2013-2018E Generic Drugs Sales Price Analysis
  5.2.4 Europe 2017 Generic Drugs Market Share Analysis
5.3 China Generic Drugs Market Analysis
  5.3.1 China Generic Drugs Market Overview
  5.3.2 China 2013-2018E Generic Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 China 2013-2018E Generic Drugs Sales Price Analysis
  5.3.4 China 2017 Generic Drugs Market Share Analysis
5.4 Japan Generic Drugs Market Analysis
  5.4.1 Japan Generic Drugs Market Overview
  5.4.2 Japan 2013-2018E Generic Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Japan 2013-2018E Generic Drugs Sales Price Analysis
  5.4.4 Japan 2017 Generic Drugs Market Share Analysis
5.5 Southeast Asia Generic Drugs Market Analysis
  5.5.1 Southeast Asia Generic Drugs Market Overview
  5.5.2 Southeast Asia 2013-2018E Generic Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Southeast Asia 2013-2018E Generic Drugs Sales Price Analysis
  5.5.4 Southeast Asia 2017 Generic Drugs Market Share Analysis
5.6 India Generic Drugs Market Analysis
  5.6.1 India Generic Drugs Market Overview
  5.6.2 India 2013-2018E Generic Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2013-2018E Generic Drugs Sales Price Analysis
  5.6.4 India 2017 Generic Drugs Market Share Analysis

6 GLOBAL 2013-2018E GENERIC DRUGS SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2013-2018E Generic Drugs Sales by Type
6.2 Different Types of Generic Drugs Product Interview Price Analysis
6.3 Different Types of Generic Drugs Product Driving Factors Analysis
  6.3.1 Simple Generic Drugs Growth Driving Factor Analysis
  6.3.2 Super Generic Drugs Growth Driving Factor Analysis
  6.3.3 Biosimilars Growth Driving Factor Analysis

7 GLOBAL 2013-2018E GENERIC DRUGS SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2013-2018E Generic Drugs Consumption by Application
7.2 Different Application of Generic Drugs Product Interview Price Analysis
7.3 Different Application of Generic Drugs Product Driving Factors Analysis
  7.3.1 CNS of Generic Drugs Growth Driving Factor Analysis
  7.3.2 Cardiovascular of Generic Drugs Growth Driving Factor Analysis
  7.3.3 Genitourinary/Hormonal Drugs of Generic Drugs Growth Driving Factor Analysis
  7.3.4 Respiratory of Generic Drugs Growth Driving Factor Analysis
  7.3.5 Rheumatology of Generic Drugs Growth Driving Factor Analysis
  7.3.6 Diabetes of Generic Drugs Growth Driving Factor Analysis
  7.3.7 Oncology of Generic Drugs Growth Driving Factor Analysis
  7.3.8 Others of Generic Drugs Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF GENERIC DRUGS

8.1 Teva
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 Teva 2017 Generic Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Teva 2017 Generic Drugs Business Region Distribution Analysis
8.2 Novartis - Sandoz
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 Novartis - Sandoz 2017 Generic Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Novartis - Sandoz 2017 Generic Drugs Business Region Distribution Analysis
8.3 Mylan
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 Mylan 2017 Generic Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Mylan 2017 Generic Drugs Business Region Distribution Analysis
8.4 Sun Pharmaceutical
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 Sun Pharmaceutical 2017 Generic Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Sun Pharmaceutical 2017 Generic Drugs Business Region Distribution Analysis
8.5 Aspen
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Product A
    8.5.2.2 Product B
  8.5.3 Aspen 2017 Generic Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Aspen 2017 Generic Drugs Business Region Distribution Analysis
8.6 Fresenius Kabi
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Product A
    8.6.2.2 Product B
  8.6.3 Fresenius Kabi 2017 Generic Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 Fresenius Kabi 2017 Generic Drugs Business Region Distribution Analysis
8.7 Pfizer (Hospira)
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Product A
    8.7.2.2 Product B
  8.7.3 Pfizer (Hospira) 2017 Generic Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 Pfizer (Hospira) 2017 Generic Drugs Business Region Distribution Analysis
8.8 Sanofi
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
    8.8.2.1 Product A
    8.8.2.2 Product B
  8.8.3 Sanofi 2017 Generic Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 Sanofi 2017 Generic Drugs Business Region Distribution Analysis
8.9 Aurobindo
  8.9.1 Company Profile
  8.9.2 Product Picture and Specifications
    8.9.2.1 Product A
    8.9.2.2 Product B
  8.9.3 Aurobindo 2017 Generic Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.9.4 Aurobindo 2017 Generic Drugs Business Region Distribution Analysis
8.10 Lupin
  8.10.1 Company Profile
  8.10.2 Product Picture and Specifications
    8.10.2.1 Product A
    8.10.2.2 Product B
  8.10.3 Lupin 2017 Generic Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.10.4 Lupin 2017 Generic Drugs Business Region Distribution Analysis
8.11 Dr. Reddy's
8.12 Apotex
8.13 Cipla
8.14 ENDO (Par Pharmaceutical)
8.15 Stada Arzneimittel
8.16 Krka Group
8.17 Nichi-Iko Pharmaceutical
8.18 Valeant
8.19 Zydus Cadila
8.20 Hikma

9 DEVELOPMENT TREND OF ANALYSIS OF GENERIC DRUGS MARKET

9.1 Global Generic Drugs Market Trend Analysis
  9.1.1 Global 2018-2025 Generic Drugs Market Size (Volume and Value) Forecast
  9.1.2 Global 2018-2025 Generic Drugs Sales Price Forecast
9.2 Generic Drugs Regional Market Trend
  9.2.1 North America 2018-2025 Generic Drugs Consumption Forecast
  9.2.2 Europe 2018-2025 Generic Drugs Consumption Forecast
  9.2.3 China 2018-2025 Generic Drugs Consumption Forecast
  9.2.4 Japan 2018-2025 Generic Drugs Consumption Forecast
  9.2.5 Southeast Asia 2018-2025 Generic Drugs Consumption Forecast
  9.2.6 India 2018-2025 Generic Drugs Consumption Forecast
9.3 Generic Drugs Market Trend (Product Type)
9.4 Generic Drugs Market Trend (Application)

10 GENERIC DRUGS MARKETING TYPE ANALYSIS

10.1 Generic Drugs Regional Marketing Type Analysis
10.2 Generic Drugs International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Generic Drugs by Region
10.4 Generic Drugs Supply Chain Analysis

11 CONSUMERS ANALYSIS OF GENERIC DRUGS

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL GENERIC DRUGS MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Generic Drugs
Table Product Specifications of Generic Drugs
Table Classification of Generic Drugs
Figure Global Production Market Share of Generic Drugs by Type in 2017
Figure Simple Generic Drugs Picture
Table Major Manufacturers of Simple Generic Drugs
Figure Super Generic Drugs Picture
Table Major Manufacturers of Super Generic Drugs
Figure Biosimilars Picture
Table Major Manufacturers of Biosimilars
Table Applications of Generic Drugs
Figure Global Consumption Volume Market Share of Generic Drugs by Application in 2017
Figure CNS Examples
Table Major Consumers in CNS
Figure Cardiovascular Examples
Table Major Consumers in Cardiovascular
Figure Genitourinary/Hormonal Drugs Examples
Table Major Consumers in Genitourinary/Hormonal Drugs
Figure Respiratory Examples
Table Major Consumers in Respiratory
Figure Rheumatology Examples
Table Major Consumers in Rheumatology
Figure Diabetes Examples
Table Major Consumers in Diabetes
Figure Oncology Examples
Table Major Consumers in Oncology
Figure Others Examples
Table Major Consumers in Others
Figure Market Share of Generic Drugs by Regions
Figure North America Generic Drugs Market Size (Million USD) (2013-2025)
Figure Europe Generic Drugs Market Size (Million USD) (2013-2025)
Figure China Generic Drugs Market Size (Million USD) (2013-2025)
Figure Japan Generic Drugs Market Size (Million USD) (2013-2025)
Figure Southeast Asia Generic Drugs Market Size (Million USD) (2013-2025)
Figure India Generic Drugs Market Size (Million USD) (2013-2025)
Table Generic Drugs Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Generic Drugs in 2017
Figure Manufacturing Process Analysis of Generic Drugs
Figure Industry Chain Structure of Generic Drugs
Table Capacity and Commercial Production Date of Global Generic Drugs Major Manufacturers in 2017
Table Manufacturing Plants Distribution of Global Generic Drugs Major Manufacturers in 2017
Table R&D Status and Technology Source of Global Generic Drugs Major Manufacturers in 2017
Table Raw Materials Sources Analysis of Global Generic Drugs Major Manufacturers in 2017
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of Generic Drugs 2013-2018E
Figure Global 2013-2018E Generic Drugs Market Size (Volume) and Growth Rate
Figure Global 2013-2018E Generic Drugs Market Size (Value) and Growth Rate
Table 2013-2018E Global Generic Drugs Capacity and Growth Rate
Table 2017 Global Generic Drugs Capacity (K MT) List (Company Segment)
Table 2013-2018E Global Generic Drugs Sales (K MT) and Growth Rate
Table 2017 Global Generic Drugs Sales (K MT) List (Company Segment)
Table 2013-2018E Global Generic Drugs Sales Price (USD/MT)
Table 2017 Global Generic Drugs Sales Price (USD/MT) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K MT) of Generic Drugs 2013-2018E
Figure North America 2013-2018E Generic Drugs Sales Price (USD/MT)
Figure North America 2017 Generic Drugs Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K MT) of Generic Drugs 2013-2018E
Figure Europe 2013-2018E Generic Drugs Sales Price (USD/MT)
Figure Europe 2017 Generic Drugs Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K MT) of Generic Drugs 2013-2018E
Figure China 2013-2018E Generic Drugs Sales Price (USD/MT)
Figure China 2017 Generic Drugs Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K MT) of Generic Drugs 2013-2018E
Figure Japan 2013-2018E Generic Drugs Sales Price (USD/MT)
Figure Japan 2017 Generic Drugs Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K MT) of Generic Drugs 2013-2018E
Figure Southeast Asia 2013-2018E Generic Drugs Sales Price (USD/MT)
Figure Southeast Asia 2017 Generic Drugs Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K MT) of Generic Drugs 2013-2018E
Figure India 2013-2018E Generic Drugs Sales Price (USD/MT)
Figure India 2017 Generic Drugs Sales Market Share
Table Global 2013-2018E Generic Drugs Sales (K MT) by Type
Table Different Types Generic Drugs Product Interview Price
Table Global 2013-2018E Generic Drugs Sales (K MT) by Application
Table Different Application Generic Drugs Product Interview Price
Table Teva Information List
Table Product Overview
Table 2017 Teva Generic Drugs Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2017 Teva Generic Drugs Business Region Distribution
Table Novartis - Sandoz Information List
Table Product Overview
Table 2017 Novartis - Sandoz Generic Drugs Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2017 Novartis - Sandoz Generic Drugs Business Region Distribution
Table Mylan Information List
Table Product Overview
Table 2017 Mylan Generic Drugs Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2017 Mylan Generic Drugs Business Region Distribution
Table Sun Pharmaceutical Information List
Table Product Overview
Table 2017 Sun Pharmaceutical Generic Drugs Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2017 Sun Pharmaceutical Generic Drugs Business Region Distribution
Table Aspen Information List
Table Product Overview
Table 2017 Aspen Generic Drugs Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2017 Aspen Generic Drugs Business Region Distribution
Table Fresenius Kabi Information List
Table Product Overview
Table 2017 Fresenius Kabi Generic Drugs Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2017 Fresenius Kabi Generic Drugs Business Region Distribution
Table Pfizer (Hospira) Information List
Table Product Overview
Table 2017 Pfizer (Hospira) Generic Drugs Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2017 Pfizer (Hospira) Generic Drugs Business Region Distribution
Table Sanofi Information List
Table Product Overview
Table 2017 Sanofi Generic Drugs Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2017 Sanofi Generic Drugs Business Region Distribution
Table Aurobindo Information List
Table Product Overview
Table 2017 Aurobindo Generic Drugs Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2017 Aurobindo Generic Drugs Business Region Distribution
Table Lupin Information List
Table Product Overview
Table 2017 Lupin Generic Drugs Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2017 Lupin Generic Drugs Business Region Distribution
Table Dr. Reddy's Information List
Table Apotex Information List
Table Cipla Information List
Table ENDO (Par Pharmaceutical) Information List
Table Stada Arzneimittel Information List
Table Krka Group Information List
Table Nichi-Iko Pharmaceutical Information List
Table Valeant Information List
Table Zydus Cadila Information List
Table Hikma Information List
Figure Global 2018-2025 Generic Drugs Market Size (K MT) and Growth Rate Forecast
Figure Global 2018-2025 Generic Drugs Market Size (Million USD) and Growth Rate Forecast
Figure Global 2018-2025 Generic Drugs Sales Price (USD/MT) Forecast
Figure North America 2018-2025 Generic Drugs Consumption Volume (K MT) and Growth Rate Forecast
Figure China 2018-2025 Generic Drugs Consumption Volume (K MT) and Growth Rate Forecast
Figure Europe 2018-2025 Generic Drugs Consumption Volume (K MT) and Growth Rate Forecast
Figure Southeast Asia 2018-2025 Generic Drugs Consumption Volume (K MT) and Growth Rate Forecast
Figure Japan 2018-2025 Generic Drugs Consumption Volume (K MT) and Growth Rate Forecast
Figure India 2018-2025 Generic Drugs Consumption Volume (K MT) and Growth Rate Forecast
Table Global Sales Volume (K MT) of Generic Drugs by Type 2018-2025
Table Global Consumption Volume (K MT) of Generic Drugs by Application 2018-2025
Table Traders or Distributors with Contact Information of Generic Drugs by Region